repro medsystems inc is a company based out of 24 carpenter road, chester, new york, united states.
Company profile
Ticker
KRMD
Exchange
Website
CEO
Donald B. Pettigrew
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Former names
REPRO MED SYSTEMS INC
SEC CIK
Corporate docs
IRS number
133044880
KRMD stock data
Latest filings (excl ownership)
8-K
KORU Medical Systems Announces Successful Appeal in EU Notified Body Review
11 Apr 24
DEF 14A
Definitive proxy
28 Mar 24
PRE 14A
Preliminary proxy
18 Mar 24
8-K
Full Year Financial Results, and 2024 Guidance
13 Mar 24
10-K
2023 FY
Annual report
13 Mar 24
10-Q
2023 Q3
Quarterly report
8 Nov 23
8-K
KORU MEDICAL SYSTEMS, INC. ANNOUNCES 2023 THIRD QUARTER FINANCIAL RESULTS and updates full year 2023 outlook
8 Nov 23
8-K
Koru Medical Systems, Inc. Announces Appointment of Edward Wholihan to Its Board of Directors
4 Oct 23
10-Q
2023 Q2
Quarterly report
9 Aug 23
8-K
Koru Medical Systems, Inc. Announces 2023 Second Quarter Financial Results and Updates Full Year 2023 Outlook
9 Aug 23
Transcripts
KRMD
Earnings call transcript
2023 Q4
13 Mar 24
KRMD
Earnings call transcript
2023 Q3
8 Nov 23
KRMD
Earnings call transcript
2023 Q2
9 Aug 23
KRMD
Earnings call transcript
2023 Q1
4 May 23
KRMD
Earnings call transcript
2022 Q4
8 Mar 23
KRMD
Earnings call transcript
2022 Q3
12 Nov 22
KRMD
Earnings call transcript
2022 Q2
7 Aug 22
KRMD
Earnings call transcript
2022 Q1
8 May 22
KRMD
Earnings call transcript
2021 Q4
3 Mar 22
KRMD
Earnings call transcript
2021 Q3
11 Nov 21
Latest ownership filings
4
Joseph M. Jr. Manko
1 Apr 24
4
EDWARD WHOLIHAN
1 Apr 24
4
Shahriar Matin
1 Apr 24
4
Donna French
1 Apr 24
4
R JOHN FLETCHER
1 Apr 24
4
ROBERT CASCELLA
1 Apr 24
4
Linda M Tharby
15 Mar 24
4
Joseph M. Jr. Manko
16 Feb 24
SC 13G
First Light Asset Management, LLC
14 Feb 24
SC 13G/A
Archon Capital Management LLC
13 Feb 24
Financial summary
Quarter (USD) | Sep 23 | Jun 23 | Mar 23 | Dec 22 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 22 | Dec 21 | Dec 20 | Dec 19 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 10.77 mm | 10.77 mm | 10.77 mm | 10.77 mm | 10.77 mm | 10.77 mm |
Cash burn (monthly) | 315.74 k | 472.42 k | 597.01 k | 881.99 k | 391.61 k | 387.74 k |
Cash used (since last report) | 2.16 mm | 3.23 mm | 4.08 mm | 6.02 mm | 2.67 mm | 2.65 mm |
Cash remaining | 8.62 mm | 7.55 mm | 6.70 mm | 4.75 mm | 8.10 mm | 8.12 mm |
Runway (months of cash) | 27.3 | 16.0 | 11.2 | 5.4 | 20.7 | 21.0 |
Institutional ownership, Q3 2023
60.7% owned by funds/institutions
13F holders | Current |
---|---|
Total holders | 55 |
Opened positions | 5 |
Closed positions | 13 |
Increased positions | 17 |
Reduced positions | 13 |
13F shares | Current |
---|---|
Total value | 49.20 bn |
Total shares | 27.76 mm |
Total puts | 2.50 k |
Total calls | 2.50 k |
Total put/call ratio | 1.0 |
Largest owners | Shares | Value |
---|---|---|
Horton Capital Partners | 9.78 mm | $0.00 |
First Light Asset Management | 5.29 mm | $14.28 bn |
Archon Capital Management | 3.56 mm | $9.62 bn |
Vanguard | 1.89 mm | $5.10 bn |
BLK Blackrock | 1.56 mm | $4.21 bn |
272 Capital | 833.66 k | $2.25 bn |
Albion Financial | 792.71 k | $2.14 bn |
Geode Capital Management | 736.88 k | $1.99 bn |
Meros Investment Management | 515.40 k | $1.39 bn |
STT State Street | 476.87 k | $1.29 bn |
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
31 Mar 24 | Manko Joseph M. Jr. | Common Stock | Grant | Acquire A | Yes | No | 0 | 6,329 | 0.00 | 7,594,709 |
31 Mar 24 | Wholihan Edward | Common Stock | Grant | Acquire A | No | No | 2.37 | 6,329 | 15.00 k | 12,777 |
31 Mar 24 | Shahriar Matin | Common Stock | Grant | Acquire A | No | No | 2.37 | 6,329 | 15.00 k | 62,609 |
31 Mar 24 | Donna French | Common Stock | Grant | Acquire A | No | No | 2.37 | 6,329 | 15.00 k | 59,979 |
31 Mar 24 | Fletcher R John | Common Stock | Grant | Acquire A | No | No | 2.37 | 9,493 | 22.50 k | 174,353 |
News
KORU Medical Systems Announces Successful Appeal In EU Notified Body Review
11 Apr 24
B. Riley Securities Reiterates Buy on KORU Medical Systems, Maintains $4 Price Target
14 Mar 24
Recap: KORU Medical Systems Q4 Earnings
13 Mar 24
KORU Medical Systems Q4 2023 Adj EPS $(0.02) Beats $(0.04) Estimate, Sales $7.186M Beat $6.944M Estimate
13 Mar 24
Earnings Scheduled For March 13, 2024
13 Mar 24